Source:http://linkedlifedata.com/resource/pubmed/id/11283678
Switch to
| Predicate | Object |
|---|---|
| rdf:type | |
| lifeskim:mentions | |
| pubmed:issue |
4
|
| pubmed:dateCreated |
2001-4-3
|
| pubmed:abstractText |
New-variant Creutzfeldt-Jakob disease and scrapie are typically initiated by extracerebral exposure to the causative agent, and exhibit early prion replication in lymphoid organs. In mouse scrapie, depletion of B-lymphocytes prevents neuropathogenesis after intraperitoneal inoculation, probably due to impaired lymphotoxin-dependent maturation of follicular dendritic cells (FDCs), which are a major extracerebral prion reservoir. FDCs trap immune complexes with Fc-gamma receptors and C3d/C4b-opsonized antigens with CD21/CD35 complement receptors. We examined whether these mechanisms participate in peripheral prion pathogenesis. Depletion of circulating immunoglobulins or of individual Fc-gamma receptors had no effect on scrapie pathogenesis if B-cell maturation was unaffected. However, mice deficient in C3, C1q, Bf/C2, combinations thereof or complement receptors were partially or fully protected against spongiform encephalopathy upon intraperitoneal exposure to limiting amounts of prions. Splenic accumulation of prion infectivity and PrPSc was delayed, indicating that activation of specific complement components is involved in the initial trapping of prions in lymphoreticular organs early after infection.
|
| pubmed:commentsCorrections | |
| pubmed:language |
eng
|
| pubmed:journal | |
| pubmed:citationSubset |
IM
|
| pubmed:chemical | |
| pubmed:status |
MEDLINE
|
| pubmed:month |
Apr
|
| pubmed:issn |
1078-8956
|
| pubmed:author |
pubmed-author:Acha-OrbeaHH,
pubmed-author:AguzziAA,
pubmed-author:BottyCC,
pubmed-author:CarrollM CMC,
pubmed-author:KaeserP SPS,
pubmed-author:KalinkeUU,
pubmed-author:KleinM AMA,
pubmed-author:MolinaHH,
pubmed-author:SchwarzPP,
pubmed-author:VerbeekJ SJS,
pubmed-author:WalportM JMJ,
pubmed-author:WeydHH,
pubmed-author:XenariosII,
pubmed-author:ZinkernagelR MRM
|
| pubmed:issnType |
Print
|
| pubmed:volume |
7
|
| pubmed:owner |
NLM
|
| pubmed:authorsComplete |
Y
|
| pubmed:pagination |
488-92
|
| pubmed:dateRevised |
2006-11-15
|
| pubmed:meshHeading |
pubmed-meshheading:11283678-Animals,
pubmed-meshheading:11283678-Base Sequence,
pubmed-meshheading:11283678-Brain,
pubmed-meshheading:11283678-Complement System Proteins,
pubmed-meshheading:11283678-DNA Primers,
pubmed-meshheading:11283678-Disease Models, Animal,
pubmed-meshheading:11283678-Humans,
pubmed-meshheading:11283678-Mice,
pubmed-meshheading:11283678-Mice, Inbred BALB C,
pubmed-meshheading:11283678-Mice, Inbred C57BL,
pubmed-meshheading:11283678-Mice, Knockout,
pubmed-meshheading:11283678-Mice, Transgenic,
pubmed-meshheading:11283678-Prion Diseases,
pubmed-meshheading:11283678-Prions,
pubmed-meshheading:11283678-Receptors, Complement,
pubmed-meshheading:11283678-Scrapie,
pubmed-meshheading:11283678-Spleen,
pubmed-meshheading:11283678-Time Factors
|
| pubmed:year |
2001
|
| pubmed:articleTitle |
Complement facilitates early prion pathogenesis.
|
| pubmed:affiliation |
Institute of Neuropathology, University of Zurich, Schmelzbergstrasse, Zurich, Switzerland.
|
| pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|